2011Vestnik dermatologii i venerologiiOpen access

Assessment of the efficacy of antihistamine drugs in complex treatment of chronic itchingdermatoses

Nikolay N. Murashkin, М. И. Глузмин, Alexander I. Materikin, Nikolay N. Murashkin, М. И. Глузмин, A I Materi kin

Open full text 0 citations

Abstract

The authors give a review of current concepts of mechanisms of skin itching development for different types of chronic dermatoses. The authors also present the results of a study aimed at assessing the efficacy of different 2nd generation antihistamine drugs used for complex treatment of 83 patients aged 14-73 suffering from different chronic itching dermatoses (atopic dermatitis, eczema, pruritus, chronic urticaria, progressing psoriasis, lichen acuminatus, contact allergic dermatitis). The authors conclude that Glencet (levocetirizine) used in a complex therapy of dermatoses accompanied with itching can efficiently arrest both subjective itching sensations and objective clinical symptoms of the diseases as well as reliably (р < 0.001) reduce the term of inpatient care by 4.8 ± 2.3 on average. Glencet (levocetirizine) is a drug of choice among the 2nd generation antihistamine drugs used for treatment of chronic skin diseases accompanied with itching.

Open-access reader

About this research paper

What this paper is about

The authors give a review of current concepts of mechanisms of skin itching development for different types of chronic dermatoses. The authors also present the results of a study aimed at assessing the efficacy of different 2nd generation antihistamine drugs used for complex treatment of 83 patients aged 14-73 suffering from different chronic itching dermatoses (atopic dermatitis, eczema, pruritus, chronic urticaria, progressing psoriasis, lichen acuminatus, contact allergic dermatitis). The authors conclude that Glencet (levocetirizine) used in a complex therapy of dermatoses accompanied with itching can efficiently arrest both subjective itching sensations and objective clinical symptoms of the diseases as well as reliably (р < 0.001) reduce the term of inpatient care by 4.8 ± 2.3 on average. Glencet (levocetirizine) is a drug of choice among the 2nd generation antihistamine drugs used for treatment of chronic skin diseases accompanied with itching.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

The authors give a review of current concepts of mechanisms of skin itching development for different types of chronic dermatoses. The authors also present the results of a study aimed at assessing the efficacy of different 2nd generation antihistamine drugs used for complex treatment of 83 patients aged 14-73 suffering from different chronic itching dermatoses (atopic dermatitis, eczema, pruritus, chronic urticaria, progressing psoriasis, lichen acuminatus, contact allergic dermatitis). The authors conclude that Glencet (levocetirizine) used in a complex therapy of dermatoses accompanied with itching can efficiently arrest both subjective itching sensations and objective clinical symptoms of the diseases as well as reliably (р < 0.001) reduce the term of inpatient care by 4.8 ± 2.3 on average. Glencet (levocetirizine) is a drug of choice among the 2nd generation antihistamine drugs used for treatment of chronic skin diseases accompanied with itching.

Key concepts: Itching, Antihistamine, Medicine, Dermatology, Levocetirizine, Chronic urticaria, Atopic dermatitis, Psoriasis

Related papers

Back to paper searchBrowse research topicsOriginal source
Assessment of the efficacy of antihistamine drugs in complex treatment of chronic itchingdermatoses — Research Paper | ScholarLens